{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:08:49Z","timestamp":1761894529176},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Compr Ther"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/s12019-003-0023-6","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T09:06:15Z","timestamp":1179133575000},"page":"194-209","source":"Crossref","is-referenced-by-count":9,"title":["Autoimmune neuropathies"],"prefix":"10.1007","volume":"29","author":[{"given":"Tulio","family":"Bertorini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpa","family":"Narayanaswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"23_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2008-1040861","volume":"18","author":"RJ Barohn","year":"1998","unstructured":"Barohn RJ, Saperstein DS. Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy. Semin Neurol. 1998;18:49\u201361.","journal-title":"Semin Neurol."},{"key":"23_CR2","volume-title":"Immunology in Guillain-Barr\u00e9 Syndrome","author":"AH Ropper","year":"1991","unstructured":"Ropper AH, Wijdicks EFM, Truax BT. Immunology in Guillain-Barr\u00e9 Syndrome. Philadelphia, PA: F.A. Davis Co.; Chapter 5, 1991."},{"key":"23_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","volume":"18","author":"HP Hartung","year":"1995","unstructured":"Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barr\u00e9 syndrome\u2014Part 1 and Part 2. Muscle Nerve. 1995;18:137\u2013153, 154\u2013164.","journal-title":"Muscle Nerve."},{"key":"23_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00314380","volume":"236","author":"E Bollensen","year":"1989","unstructured":"Bollensen E, Schipper HI, Stack AJ. Motor neuropathy with activity of monoclonal IgM antibody to GD1: A ganglioside. J Neurol. 1989;236:353\u2013355.","journal-title":"J Neurol."},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ana.410270517","volume":"27","author":"EF Salazar-Grueso","year":"1990","unstructured":"Salazar-Grueso EF, Routbort MJ, Martin J, Dawson G, Roos RP. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol. 1990;27:558\u2013563.","journal-title":"Ann Neurol."},{"key":"23_CR6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.410270314","volume":"27","author":"A Pestronk","year":"1990","unstructured":"Pestronk A, Chaudry V, Feldman EL, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol. 1990;27:316\u2013326.","journal-title":"Ann Neurol."},{"key":"23_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2008-1041096","volume":"14","author":"JT Kissel","year":"1994","unstructured":"Kissel JT. Vasculitis of the peripheral nervous system. Semin Neurol. 1994;14:361\u2013369.","journal-title":"Semin Neurol."},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410150510","volume":"15","author":"WG Bradley","year":"1984","unstructured":"Bradley WG, Chad D, Verghese JPCD. Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate. A treatable inflammatory syndrome. Ann Neurol. 1984;15:457\u2013464.","journal-title":"Ann Neurol."},{"key":"23_CR9","first-page":"1462","volume":"40","author":"G Guillain","year":"1916","unstructured":"Guillain G, Barr\u00e9 JA, Strohl A. Sur un syndrome de radiculon\u00e9vrite avec hyperalbuminose du liquide c\u00e9phalo-rachidien sans r\u00e9action cellulaire. Remarques sur les caract\u00e8res cliniques et graphiques des r\u00e9flexes tendineux. Bulletins et m\u00e9moires de la Soci\u00e9t\u00e9 des M\u00e9decins des H\u00f4pitaux de Paris. 1916;40:1462\u20131470.","journal-title":"Bulletins et m\u00e9moires de la Soci\u00e9t\u00e9 des M\u00e9decins des H\u00f4pitaux de Paris"},{"key":"23_CR10","first-page":"472","volume":"6","author":"O Landry","year":"1859","unstructured":"Landry O. Note sur la paralysie ascendante aigue gazzette. Hebdo Madaire. 1859;6:472\u2013474.","journal-title":"Hebdo Madaire."},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","volume":"326","author":"AH Ropper","year":"1992","unstructured":"Ropper AH. Current Concepts: The Guillain-Barr\u00e9 syndrome. N Engl J Med. 1992;326:1130\u20131136.","journal-title":"N Engl J Med."},{"key":"23_CR12","volume-title":"Guillain-Barr\u00e9 Syndrome","author":"GJ Parry","year":"1993","unstructured":"Parry GJ. Guillain-Barr\u00e9 Syndrome. New York: Thieme Medical Publishers, Inc.; 1993."},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ana.410090707","volume":"S9","author":"LB Schonberger","year":"1981","unstructured":"Schonberger LB, Hurwitz ES, Katona P, Holman RC, Bregman DJ. Guillain-Barr\u00e9 syndrome: Its epidemiology and associations with influenza vaccination. Ann Neurol. 1981;S9:31\u201338.","journal-title":"Ann Neurol."},{"issue":"S","key":"23_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.410270704","volume":"27","author":"M Alter","year":"1990","unstructured":"Alter M. The epidemiology of Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990;27(S):S7\u201312.","journal-title":"Ann Neurol."},{"key":"23_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0022-510X(87)90099-2","volume":"81","author":"J Cabrera","year":"1987","unstructured":"Cabrera J, Griffin DE, Johnson RT. Unusual features of the Guillain-Barr\u00e9 syndrome after rabies vaccine prepared in suckling mouse brain. J Neurol Sci. 1987;81:239\u2013245.","journal-title":"J Neurol Sci."},{"key":"23_CR16","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM199511233332110","volume":"333","author":"JH Rees","year":"1995","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome. N Engl J Med. 1995;333:1415\u20131417.","journal-title":"N Engl J Med."},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM199511233332110","volume":"333","author":"CF Bolton","year":"1995","unstructured":"Bolton CF. The changing concepts of Guillian-Barr\u00e9 syndrome. N Engl J Med. 1995;333:1415\u20131417.","journal-title":"N Engl J Med."},{"key":"23_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.410340204","volume":"34","author":"JW Griffin","year":"1993","unstructured":"Griffin JW, Ho TW. The Guillain-Barr\u00e9 syndrome at 75: The Campylobacter connection. Ann Neurol. 1993;34:125\u2013127.","journal-title":"Ann Neurol."},{"key":"23_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","volume":"48","author":"AK Asbury","year":"1969","unstructured":"Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine. 1969;48:173\u2013215.","journal-title":"Medicine."},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.410150209","volume":"15","author":"BM Harrison","year":"1984","unstructured":"Harrison BM, Hansen LA, Pollard JD, McLeod JG. Demyelianbion induced by serum from patients with Guillain-Barr\u00e9 syndrome. Ann Neurol. 1984;15:163\u2013170.","journal-title":"Ann Neurol."},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ana.410110112","volume":"11","author":"T Saida","year":"1982","unstructured":"Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK. In vivo demyelianting activity of sera from patients with Guillain-Barr\u00e9 syndrome. Ann Neurol. 1982;11:69\u201375.","journal-title":"Ann Neurol."},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00005072-197104000-00007","volume":"30","author":"A Hirano","year":"1971","unstructured":"Hirano A, Cook SD, Whitaker JN, Dowling PC, Murray MR. Fine structural aspects of demyelination in vitro. The effects of Guillain-Barr\u00e9 serum. J. Neuropath Exp Neurol. 1971;30:249\u2013265.","journal-title":"J. Neuropath Exp Neurol."},{"issue":"2","key":"23_CR23","first-page":"2","volume":"1","author":"CL Koski","year":"1989","unstructured":"Koski CL. Guillain-Barr\u00e9 syndrome. Autoimmunity Forum. Neurology. 1989;1(2):2\u20134.","journal-title":"Neurology."},{"key":"23_CR24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1172\/JCI114152","volume":"84","author":"CL Koski","year":"1989","unstructured":"Koski CL, Chou DKH, Jungalwala FB. Anti-peripheral nerve myelin antibodies in Guillain-Barr\u00e9 syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J Clin Invest. 1989;84:280\u2013287.","journal-title":"J Clin Invest."},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archneur.1991.00530200100027","volume":"48","author":"FJ Vriesendorp","year":"1991","unstructured":"Vriesendorp FJ, Mayer RF, Koski CL. Kinetics of antiperipheral nerve myelin antibody in patients with Guillain-Barr\u00e9 syndrome treated and not treated with plasmapheresis. Arch Neurol. 1991;48:858\u2013861.","journal-title":"Arch Neurol."},{"key":"23_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","volume":"30","author":"HP Hartung","year":"1991","unstructured":"Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV. Serum interleukin-2 concentration in Guillain-Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol. 1991;30:48\u201353.","journal-title":"Ann Neurol."},{"key":"23_CR27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.410340206","volume":"34","author":"FJ Vriesendorp","year":"1993","unstructured":"Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barr\u00e9 syndrome and controls: Correlation and prognosis. Ann Neurol. 1993;34:130\u2013135.","journal-title":"Ann Neurol."},{"key":"23_CR28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.410230503","volume":"23","author":"AA Ilyas","year":"1988","unstructured":"Ilyas AA, Willison HG, Quarles RH, et al. Serum antibodies to gangliosides in Guillain-Barr\u00e9 syndrome. Ann Neurol. 1988;23:440\u2013447.","journal-title":"Ann Neurol."},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ana.410370704","volume":"37","author":"FGA Mech\u00e9 van der","year":"1995","unstructured":"van der Mech\u00e9 FGA, van Doorn PA. Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies. Ann Neurol. 1995;37:S14\u201331.","journal-title":"Ann Neurol."},{"key":"23_CR30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.410380208","volume":"38","author":"PG Oomes","year":"1995","unstructured":"Oomes PG, Jacobs BC, Hazenberg MP, Banffer JR, van Mech\u00e9 FG. Anti-GM1, IgG antibodies and Campylobacter bacteria in Guillain-Barr\u00e9 syndrome: Evidence of molecular mimicry. Ann Neurol. 1995;38:170\u2013175.","journal-title":"Ann Neurol."},{"key":"23_CR31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ana.410380516","volume":"38","author":"JH Rees","year":"1995","unstructured":"Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barr\u00e9 syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol. 1995;38:809\u2013816.","journal-title":"Ann Neurol."},{"key":"23_CR32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1212\/WNL.47.3.668","volume":"47","author":"LH Visser","year":"1996","unstructured":"Visser LH, van der Mech\u00e9 FGA, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barr\u00e9 syndrome: The clinical, electrophysiologic, and prognostic features. Neurology. 1996;47:668\u2013673.","journal-title":"Neurology."},{"key":"23_CR33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.56.2.204","volume":"56","author":"HJ Willison","year":"1993","unstructured":"Willison HJ, Weitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993;56:204\u2013206.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"23_CR34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.43.2.414","volume":"43","author":"N Yuki","year":"1993","unstructured":"Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology. 1993;43:414\u2013417.","journal-title":"Neurology."},{"key":"23_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990;27:S21\u201324.","journal-title":"Ann Neurol."},{"key":"23_CR36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/mus.880080609","volume":"8","author":"JW Albers","year":"1985","unstructured":"Albers JW, Donofrio PD, McGonable TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1985;8:528\u2013539.","journal-title":"Muscle Nerve."},{"key":"23_CR37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410270706","volume":"27","author":"D Cornblath","year":"1990","unstructured":"Cornblath D. Electrophysiology in Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990;27:S17\u201320.","journal-title":"Ann Neurol."},{"key":"23_CR38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ana.410230407","volume":"23","author":"DR Cornblath","year":"1988","unstructured":"Cornblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barr\u00e9 syndrome: Description and prognostic value. Ann Neurol. 1988;23:354\u2013359.","journal-title":"Ann Neurol."},{"key":"23_CR39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/brain\/107.1.219","volume":"107","author":"WF Brown","year":"1984","unstructured":"Brown WF, Feasby TE. Conduction block and denervation in Guillain-Barr\u00e9 polyneuropathy. Brain. 1984;107:219\u2013239.","journal-title":"Brain."},{"key":"23_CR40","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/archneur.1986.00520110044012","volume":"43","author":"AH Ropper","year":"1986","unstructured":"Ropper AH. Unusual clinical variants and signs in Guillain-Barr\u00e9 syndrome. Arch Neurol. 1986;43:1150\u20131152.","journal-title":"Arch Neurol."},{"key":"23_CR41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","volume":"33","author":"GM McKhann","year":"1993","unstructured":"McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993;33:333\u2013342.","journal-title":"Ann Neurol."},{"key":"23_CR42","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","volume":"109","author":"TE Feasby","year":"1986","unstructured":"Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barr\u00e9 polyneuropathy. Brain. 1986;109:1115\u20131126.","journal-title":"Brain."},{"key":"23_CR43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1212\/WNL.48.3.717","volume":"48","author":"TW Ho","year":"1997","unstructured":"Ho TW, Hsieh ST, Nachamkin I, et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter inflammation. Neurology. 1997;48:717\u2013724.","journal-title":"Neurology."},{"key":"23_CR44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","volume":"39","author":"JW Griffin","year":"1996","unstructured":"Griffin JW, Li CY, Ho TW, et al. Pathology of the motorsensory axonal Guillain-Barr\u00e9 syndrome. Ann Neurol. 1996;39:17\u201328.","journal-title":"Ann Neurol."},{"key":"23_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","volume":"255","author":"CM Fisher","year":"1956","unstructured":"Fisher CM. An unusual variant of acute idiopathic poly-neuritis (syndrome of ophthalmoplegia, ataxia, and areflexia). N Engl J Med. 1956;255:57\u201365.","journal-title":"N Engl J Med."},{"key":"23_CR46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/brain\/98.4.613","volume":"98","author":"RR Young","year":"1975","unstructured":"Young RR, Asbury AK, Corbett JL, Adams RD. Pure pandysautonomia with recovery. Brain. 1975;98:613\u2013636.","journal-title":"Brain."},{"key":"23_CR47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0404.1992.tb04045.x","volume":"85","author":"E Gibbels","year":"1992","unstructured":"Gibbels E, Giebisch V. Natural course of acute and chronic monophasic inflammatory demyelinating polyneuropathies (IDP). A retrospective analysis of 266 cases. Acta Neurol Scand. 1992;85:282\u2013291.","journal-title":"Acta Neurol Scand."},{"key":"23_CR48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/jnnp.49.5.563","volume":"49","author":"CF Bolton","year":"1986","unstructured":"Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry. 1986;49:563\u2013573.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"23_CR49","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","volume":"35","author":"The Guillain-Barr\u00e9 syndrome study group","year":"1985","unstructured":"The Guillain-Barr\u00e9 syndrome study group. Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. Neurology. 1985;35:1096\u20131104.","journal-title":"Neurology."},{"key":"23_CR50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","volume":"349","author":"Plasma Exchange Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","year":"1997","unstructured":"Plasma Exchange Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 lain-Barr\u00e9 syndrome. Lancet. 1997;349:225\u2013230.","journal-title":"Lancet."},{"key":"23_CR51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","volume":"326","author":"FGA Mech\u00e9 Van der","year":"1992","unstructured":"Van der Mech\u00e9 FGA, Schmitz PIM, Dutch Guillain-Barr\u00e9 Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. N Engl J Med. 1992;326:1123\u20131129.","journal-title":"N Engl J Med"},{"key":"23_CR52","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/WNL.35.11.1551","volume":"35","author":"JR Mendell","year":"1985","unstructured":"Mendell JR, Kissel JT, Kennedy MS, et al. Plasma exchange and prednisone in Guillain-Barr\u00e9 syndrome. A controlled randomized trial. Neurology. 1985;35:1551\u20131555.","journal-title":"Neurology"},{"key":"23_CR53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N","volume":"19","author":"TE Bertorini","year":"1996","unstructured":"Bertorini TE, Nance A, Horner LH, Greene W, Gelfand MS, Jaster JH. Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve. 1996;19: 388\u2013391.","journal-title":"Muscle Nerve"},{"key":"23_CR54","first-page":"621","volume":"50","author":"PJ Dyck","year":"1975","unstructured":"Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculo-neuropathy. Mayo Clin Proc. 1975;50:621\u2013637.","journal-title":"Mayo Clin Proc"},{"issue":"S","key":"23_CR55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ana.410090719","volume":"9","author":"MC Dalakas","year":"1981","unstructured":"Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: Pathogenesis and treatment. Ann Neurol. 1981;9(S):134\u2013145.","journal-title":"Ann Neurol"},{"key":"23_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-510X(96)00126-8","volume":"142","author":"JD Stewart","year":"1996","unstructured":"Stewart JD, McKelvey R, Duncan L, Carpenter S, Karpati G. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetes. J Neurol Sci. 1996;142:59\u201364.","journal-title":"J Neurol Sci"},{"key":"23_CR57","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/WNL.37.8.1291","volume":"37","author":"JR Mendell","year":"1987","unstructured":"Mendell JR, Kolkin S, Kissell JT, Weiss KL, Chakeres DW, Rammohan KW. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 1987;37:1291\u20131294.","journal-title":"Neurology"},{"key":"23_CR58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/jon1995519","volume":"5","author":"T Bertorini","year":"1995","unstructured":"Bertorini T, Halford H, Lawrence J, Vo D, Wassef M. Contrast-enhanced magnetic resonance imaging of the lumbosacral roots in the dysimmune inflammatory polyneuropathies. J Neuroimaging (US). 1995;5:9\u201315.","journal-title":"J Neuroimaging (US)"},{"key":"23_CR59","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1212\/WNL.43.3_Part_1.618","volume":"43","author":"GW Morgan","year":"1993","unstructured":"Morgan GW, Barohn RJ, Bazan C, King RB, Klucznik RP. Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy. Neurology. 1993;43:618\u2013620.","journal-title":"Neurology"},{"key":"23_CR60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0022-510X(94)90070-1","volume":"127","author":"K Matsummuro","year":"1994","unstructured":"Matsummuro K, Izumo S, Umehara F, Osame M. Chronic inflammatory demyelinating polyneuropathy: Histological and immunopathological studies in biopsied sural nerves. J Neurol Sci. 1994;127:170\u2013178.","journal-title":"J Neurol Sci"},{"key":"23_CR61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","volume":"41","author":"DR Cornblath","year":"1991","unstructured":"Cornblath DR, Asbury AK, Albers JW, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 1991;41:617\u2013618.","journal-title":"Neurology"},{"key":"23_CR62","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","volume":"46","author":"RJ Barohn","year":"1989","unstructured":"Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy: Clinical characteristics, course and recommendations for diagnostic criteria. Arch Neurol. 1989;46:878\u2013884.","journal-title":"Arch Neurol"},{"key":"23_CR63","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mus.880150219","volume":"15","author":"SJ Oh","year":"1992","unstructured":"Oh SJ, Joy JL, Sunwoo IN, Kuruoght R. A case of chronic sensory demyelinating neuropathy responding to immunotherapies. Muscle Nerve. 1992;15:255\u2013256.","journal-title":"Muscle Nerve"},{"key":"23_CR64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<365::AID-MUS14>3.0.CO;2-R","volume":"19","author":"A Uncini","year":"1996","unstructured":"Uncini A, Sabatelli M, Mignogna T, Lugaresi A, Liguori R, Montagna P. Chronic progressive steroid responsive axonal polyneuropathy: A CIDP variant or a primary axonal disorder? Muscle Nerve. 1996;19:365\u2013371.","journal-title":"Muscle Nerve"},{"key":"23_CR65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(95)00149-V","volume":"133","author":"E Manfredini","year":"1995","unstructured":"Manfredini E, Nobile-Orazio E, Allaria S, Scarlato G. Antialpha-and beta-tubulin IgM antibodies in disimmune neuropathies. J Neurol Sci. 1995;133:79\u201384.","journal-title":"J Neurol Sci"},{"key":"23_CR66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF00868814","volume":"242","author":"IN Schaik van","year":"1995","unstructured":"van Schaik IN, Vermeulen M, van Doorn PA, Brand A. Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy. J Neurol. 1995;242:599\u2013603.","journal-title":"J Neurol"},{"key":"23_CR67","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1212\/WNL.51.6.1738","volume":"51","author":"MD Weiss","year":"1998","unstructured":"Weiss MD, Luciano CA, Semino-Mora C, Dalakas MC, Quarles RH. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology. 1998;51:1738\u20131741.","journal-title":"Neurology"},{"key":"23_CR68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0960-8966(95)00021-6","volume":"6","author":"JT Kissel","year":"1995","unstructured":"Kissel JT, Mendell JR. Neuropathies associated with monoclonal gammopathies. Neuromusc Disord. 1995;6:3\u201318.","journal-title":"Neuromusc Disord"},{"key":"23_CR69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","volume":"11","author":"PJ Dyck","year":"1982","unstructured":"Dyck PJ, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol. 1982;11:136\u2013141.","journal-title":"Ann Neurol"},{"key":"23_CR70","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.35.8.1173","volume":"35","author":"PJ Dyck","year":"1985","unstructured":"Dyck PJ, O'Brien P, Swanson C, Low P, Daube J. Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology. 1985;35:1173\u20131176.","journal-title":"Neurology"},{"key":"23_CR71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","volume":"314","author":"PJ Dyck","year":"1986","unstructured":"Dyck PJ, Daube J, O'Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med. 1986;314:461\u2013465.","journal-title":"N Engl J Med"},{"key":"23_CR72","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Pillay N, et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: A double-blind, sham-controlled, cross-over study. Brain. 1996;119:1055\u20131066.","journal-title":"Brain"},{"key":"23_CR73","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","volume":"36","author":"PJ Dyck","year":"1994","unstructured":"Dyck PJ, Litchy WJ, Kratz DM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 1994;36:838\u2013845.","journal-title":"Ann Neurol"},{"key":"23_CR74","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebocontrolled, cross-over study. Brain. 1996;119:1067\u20131077.","journal-title":"Brain"},{"key":"23_CR75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1212\/WNL.40.2.209","volume":"40","author":"PA Doorn Van","year":"1990","unstructured":"Van Doorn PA, Brand A, Strengers PFW, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled crossover study. Neurology. 1990;40:209\u2013212.","journal-title":"Neurology"},{"key":"23_CR76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.56.1.36","volume":"56","author":"M Vermeulen","year":"1993","unstructured":"Vermeulen M, van Doorn PA, Brand A, Stengers PF, Jennekens FG, Busch HF. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled study. J Neurol Neurosurg Psychiatry. 1993;56:36\u201339.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"23_CR77","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","volume":"325","author":"PJ Dyck","year":"1991","unstructured":"Dyck PJ, Low PA, Windebank AJ, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med. 1991;325:1482\u20131486.","journal-title":"N Engl J Med"},{"key":"23_CR78","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mus.880141002","volume":"14","author":"A Pestronk","year":"1991","unstructured":"Pestronk A. Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve. 1991;14:927\u2013936.","journal-title":"Muscle Nerve"},{"key":"23_CR79","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","volume":"24","author":"A Pestronk","year":"1988","unstructured":"Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1, ganglioside. Ann Neurol. 1988;24:73\u201378.","journal-title":"Ann Neurol"},{"key":"23_CR80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mus.880110203","volume":"11","author":"GJ Parry","year":"1988","unstructured":"Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve. 1988;11:103\u2013107.","journal-title":"Muscle Nerve"},{"key":"23_CR81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.880120106","volume":"11","author":"P Bergh Van den","year":"1989","unstructured":"Van den Bergh P, Logigian EL, Kelly J. Motor neuropathy with multifocal conduction blocks. Muscle Nerve. 1989;11:26\u201331.","journal-title":"Muscle Nerve"},{"key":"23_CR82","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.40.1.118","volume":"40","author":"C Krarup","year":"1990","unstructured":"Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA. A syndrome of asymmetric limb weakness with motor conduction block. Neurology. 1990;40:118\u2013127.","journal-title":"Neurology"},{"key":"23_CR83","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archneur.1988.00520280101025","volume":"45","author":"WG Bradley","year":"1988","unstructured":"Bradley WG, Bennett RK, Good P, Little B. Proximal chronic inflammatory polyneuropathy with multifocal conduction block. Arch Neurol. 1988;45:451\u2013455.","journal-title":"Arch Neurol"},{"key":"23_CR84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.880120106","volume":"12","author":"P Bergh Van den","year":"1989","unstructured":"Van den Bergh P, Logigian EL, Kelly JJ Jr. Motor neuropathy with multifocal conduction blocks. Muscle Nerve. 1989; 12:26\u201331.","journal-title":"Muscle Nerve"},{"key":"23_CR85","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.410270314","volume":"27","author":"A Pestronk","year":"1990","unstructured":"Pestronk A, Chaudhry V, Feldman EL, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol. 1990;27:316\u2013326.","journal-title":"Ann Neurol"},{"key":"23_CR86","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1212\/WNL.42.3.497","volume":"42","author":"DJ Lange","year":"1992","unstructured":"Lange DJ, Trojaborg W, Latov N, et al. Multifocal motor neuropathy with conduction block: Is it a distinct clinical entity? Neurology. 1992;42:497\u2013505.","journal-title":"Neurology"},{"key":"23_CR87","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/mus.880170211","volume":"17","author":"V Chaudhry","year":"1994","unstructured":"Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Freimer ML, Griffin JW. Multifocal motor neuropathy: Electrodiagnostic features. Muscle Nerve. 1994;17:198\u2013205.","journal-title":"Muscle Nerve"},{"key":"23_CR88","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1212\/WNL.48.3.700","volume":"48","author":"JS Katz","year":"1997","unstructured":"Katz JS, Wolfe GI, Bryan WW, Jackson Ce, Amato AA, Barohn RJ. Electrophysiologic findings in multifocal motor neuropathy. Neurology. 1997;48:700\u2013707.","journal-title":"Neurology"},{"key":"23_CR89","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mus.880110203","volume":"11","author":"GJ Parry","year":"1988","unstructured":"Parry GJ, Clarke S. Multifocal acquired neuropathy masquerading as motor neuron disease. Muscle Nerve. 1988;11:103\u2013107.","journal-title":"Muscle Nerve"},{"key":"23_CR90","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","volume":"57","author":"M Donaghy","year":"1994","unstructured":"Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy: Deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry. 1994;57:778\u2013783.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"23_CR91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ana.410330303","volume":"33","author":"V Chaudhry","year":"1993","unstructured":"Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: Response to human immune globulin. Ann Neurol. 1993;33:237\u2013242.","journal-title":"Ann Neurol"},{"key":"23_CR92","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","volume":"55","author":"P Federico","year":"2000","unstructured":"Federico P, Zochodne DW, Hahn AF, et al. Multifocal motor neuropathy improved by IVIG: Randomized, double-blind, placebo-controlled study. Neurology. 2000;55:1256\u20131262.","journal-title":"Neurology"},{"key":"23_CR93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","volume":"24","author":"A Pestronk","year":"1988","unstructured":"Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol. 1988;24:73\u201378.","journal-title":"Ann Neurol"},{"key":"23_CR94","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","volume":"32","author":"RA Lewis","year":"1982","unstructured":"Lewis RA, Sumner AJ, Brown MJ, Ashbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982;32:958\u2013964.","journal-title":"Neurology"},{"key":"23_CR95","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","volume":"22","author":"DS Saperstein","year":"1999","unstructured":"Saperstein DS, Amaro AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis-Sumner syndrome. Muscle Nerve. 1999;22:560\u2013566.","journal-title":"Muscle Nerve"},{"key":"23_CR96","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.58.4.615","volume":"58","author":"JS Katz","year":"2002","unstructured":"Katz JS, Barohn RJ, Kojan S, et al. Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology. 2002;58:615\u2013620.","journal-title":"Neurology"},{"key":"23_CR97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO;2-F","volume":"21","author":"B Chassande","year":"1998","unstructured":"Chassande B, Leger JM, Younes-Chennoufi AB, et al. Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M protein antibody activity and clinical\/electrophysiological features in 40 cases. Muscle Nerve. 1998;21:55\u201362.","journal-title":"Muscle Nerve"},{"key":"23_CR98","volume-title":"Peripheral Nerve Disorders II","author":"N Latov","year":"1995","unstructured":"Latov N, Steck AJ. Neuropathies associated with anti-glycoconjugate antibodies and IgM monoclonal gammopathies. In: Asbury AK, Thomas PK, eds. Peripheral Nerve Disorders II. Woburn, MA: Butterworth Heinemann; 1995."},{"key":"23_CR99","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/(SICI)1097-4598(199605)19:5<637::AID-MUS12>3.0.CO;2-K","volume":"19","author":"BL Van den","year":"1996","unstructured":"Van den BL, Hays AP, Nobile-Orazio E, Kinsella LJ, et al. Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve. 1996;19:637\u2013643.","journal-title":"Muscle Nerve"},{"key":"23_CR100","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.410400516","volume":"40","author":"MC Dalakas","year":"1996","unstructured":"Dalakas MC, Quarles RH, Farrer RG, et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol. 1996;40:792\u2013795.","journal-title":"Ann Neurol"},{"key":"23_CR101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.410240118","volume":"24","author":"E Nobile-Orazio","year":"1988","unstructured":"Nobile-Orazio E, Baldini L, Barbieri S, et al. Treatment of patients with neuropathy and anti-MAG M-proteins. Ann Neurol. 1988;24:93\u201397.","journal-title":"Ann Neurol"},{"key":"23_CR102","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1212\/WNL.45.8.1577","volume":"45","author":"G Blume","year":"1995","unstructured":"Blume G, Pestronk A, Goodnough LT. Anti-MAG antibody-associated polyneuropathies: Improvement following immunotherapy with monthly plasma exchange and IV-cyclophosphamide. Neurology. 1995;45:1577\u20131580.","journal-title":"Neurology"},{"key":"23_CR103","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","volume":"54","author":"JS Katz","year":"2000","unstructured":"Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000;54:615\u2013620.","journal-title":"Neurology"},{"key":"23_CR104","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.60.6.661","volume":"60","author":"E Apartis","year":"1996","unstructured":"Apartis E, Leger JM, Musset L, et al. Peripheral neuropathy associated with essential mixed cryoglobulinemia: A role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry. 1996;60:661\u2013666.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"23_CR105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-5728(93)90077-C","volume":"43","author":"R Nemni","year":"1993","unstructured":"Nemni R, Fazio R, Quatrini A, Lorenzetti I, Mamoli D, Canal N. Antibodies to sulfatides chondroitin sulfate C in patients with chronic sensory neuropathy. J Neuroimmunol. 1993;43:79\u201385.","journal-title":"J Neuroimmunol"},{"key":"23_CR106","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/mus.880171108","volume":"17","author":"A Pestronk","year":"1994","unstructured":"Pestronk A, Choksi R, Bieser K, et al. Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that co-purity with myelin associated glycoprotein. Muscle Nerve. 1994;17:1293\u20131300.","journal-title":"Muscle Nerve"},{"key":"23_CR107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0002-9343(86)90047-1","volume":"80","author":"F Graus","year":"1986","unstructured":"Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer an antineuronal antibody that also reacts with the tumor. Am J Med. 1986;80:45\u201352.","journal-title":"Am J Med"},{"key":"23_CR108","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/WNL.42.3.536","volume":"42","author":"F Graus","year":"1992","unstructured":"Graus F, Vega F, Delattre JY, et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology. 1992;42:536\u2013540.","journal-title":"Neurology"},{"key":"23_CR109","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-70-4-751","volume":"70","author":"HB Kaltreider","year":"1969","unstructured":"Kaltreider HB, Talal N. The neuropathy of Sj\u00f6gren's syndrome. Ann Intern Med. 1969;70:751\u2013762.","journal-title":"Ann Intern Med"},{"key":"23_CR110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410270313","volume":"27","author":"JW Griffin","year":"1990","unstructured":"Griffin JW, Cornblath DR, Alexander E, et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sj\u00f6gren's syndrome. Ann Neurol. 1990;27:304\u2013315.","journal-title":"Ann Neurol"},{"key":"23_CR111","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/art.1780150202","volume":"15","author":"DL Conn","year":"1972","unstructured":"Conn DL, McDuffie FC, Dyck PJ. Immunopathological study of sural nerves in rheumatoid arthritis. Arthritis Rheum. 1972;15:135\u2013143.","journal-title":"Arthritis Rheum"},{"key":"23_CR112","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.32.8.839","volume":"32","author":"JM Peyronnard","year":"1982","unstructured":"Peyronnard JM, Charron L, Beaudet F, Couture F. Vasculitic neuropathy in rheumatoid disease and Sj\u00f6gren's syndrome. Neurology. 1982;32:839\u2013845.","journal-title":"Neurology"},{"key":"23_CR113","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00019052-199910000-00017","volume":"12","author":"G Said","year":"1999","unstructured":"Said G. Vasculitic neuropathy. Curr Opin Neurol. 1999;12:627\u2013629.","journal-title":"Curr Opin Neurol"},{"key":"23_CR114","first-page":"149","volume":"3","author":"G Said","year":"1994","unstructured":"Said G. Inflammatory neuropathies associated with known infections (HIV, leprosy, Chagas' disease, Lyme disease). Clin Neurol. 1994;3:149\u2013171.","journal-title":"Clin Neurol"},{"key":"23_CR115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ana.410230506","volume":"23","author":"G Said","year":"1988","unstructured":"Said G, Lacroix-Claudio C, Fujimura H, Blas C, Faux N. The peripheral neuropathy of necrotizing arteritis: A clinicopathological study. Ann Neurol. 1988;23:461\u2013465.","journal-title":"Ann Neurol"},{"issue":"Pt 5","key":"23_CR116","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/brain\/119.5.1441","volume":"119","author":"L Davies","year":"1996","unstructured":"Davies L, Spies JM, Pollard JD, McLeod JG. Vasculitis confined to peripheral nerves. Brain. 1996;119(Pt 5) 1441\u20131448.","journal-title":"Brain"},{"key":"23_CR117","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/brain\/110.4.843","volume":"110","author":"PJ Dyck","year":"1987","unstructured":"Dyck PJ, Benstead TJ, Conn DL, et al. Nonsystemic vasculitic neuropathy. Brain. 1987;110:843\u2013854.","journal-title":"Brain"},{"key":"23_CR118","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.410180213","volume":"18","author":"JT Kissel","year":"1985","unstructured":"Kissel JT, Slivka AP, Warmolts JR, Mendell JR. The clinical spectrum of necrotizing angiopathy of the peripheral neurovous system. Ann Neurol. 1985;18:251\u2013257.","journal-title":"Ann Neurol"},{"key":"23_CR119","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mus.880130203","volume":"13","author":"A Ropert","year":"1990","unstructured":"Ropert A, Metral S. Conduction block in neuropathies with necrotizing vasculitis. Muscle Nerve. 1990;13:102\u2013105.","journal-title":"Muscle Nerve"}],"container-title":["Comprehensive Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12019-003-0023-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12019-003-0023-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12019-003-0023-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:48:28Z","timestamp":1559425708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12019-003-0023-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s12019-003-0023-6","relation":{},"ISSN":["0098-8243","1559-1190"],"issn-type":[{"value":"0098-8243","type":"print"},{"value":"1559-1190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}